1, 3, 4-oxadiazole emerged as an important heterocyclic nucleus for new drug development. These compounds have importance as biological targets. This article describes the various methods of synthesis and different bioactivity profiles of 1,3,4-oxadiazole ring system which have been reported within last five years and is helpful in the invention of newer compounds with antimicrobial, antimycobacterial, anti-tumor, antitubercular, anticonvulsant activities and so forth.
Introduction
1, 3, 4-oxadiazoles belong to a class of medicinally important synthetic compounds. The newer methods of preparation and differentbioactivitiesof1, 3, 4-oxadiazoles ring system reported within the last five years have been focused in this article. This heterocyclic moiety has been the keen interest area of many recent review articles [1] [2] [3] [4] [5] . Oxadiazole being a very weak base has less electron density carbon thus making it extremely resistant towards electrophilic substitutions; however its nitrogen is attacked by electrophile with electron-releasing groups [5] . Literature survey has revealed that many compounds bearing a five membered heterocyclic ring containing nitrogen and oxygen like oxadiazole; have been synthesized and reported to have anticancer, antiinflammatory and analgesic effects etc. [6] [7] [8] .
This review article describes the methods of synthesis and bio-profiles related to 1, 3, 4-oxadiazole ring system reported during the last 5 years. The synthesis of symmetrical and unsymmetrical 1, 3, 4-oxadiazolesvia an imine C-H functionalization using Cu (OTf)2 catalyst (Scheme 1)was carried out in presence of air and moisture. This way is practically feasible and thus proves its application in organic synthesis [9] . The synthesis of 2-amino-1, 3, 4-oxadiazoles and 2-amino-1, 3, 4-thiadiazoles were accomplished viaregio selcective cyclization of thiosemicarbazide with EDC·HCl in DMSO or p-TsCl, triethylamine in N-methyl-2-pyrrolidone (Scheme 3) [11] . Sangshetti et al., synthesized 1,3, 4-oxadiazole by both microwave assisted and conventional ways using sodium bisulfite in ethanol-water as a catalyst (Scheme 5). The ranges of yield were 90-95% and 87-91% from both the methods respectively [13] . Various other methods for the synthesis of 1, 3, 4-oxadizole have been reported in some of the oxadizole reviews [14] . Ahsan et al., synthesized 2, 5-disubstituted 1, 3, 4-oxadiazole analogues as novel anti-cancer agents. These compounds were also studied for prediction of molecular properties.
Synthesis of Oxadiazole

Anti Cancer Activity
Compound 4 showed maximum activity with growth percent of 95.37% against cancer cell lines [18] . The molecular docking studies for the compounds 4 showed that the residue Cys797 was present near to the para-substitution of phenyl group while the five member oxadiazole ring was lying near to Leu792 and Met793 of EGFR tyrosine kinase active site.
Qian-Ru et al., designed and synthesized 1, 3, 4-oxadiazole thioether analogues, their thymidylate synthase (TS) and anticancer activities were also evaluated. Among all the designed compounds, compound 5 bearing a nitro group showed more potency towards in vitro anticancer activities with IC50 values of 0.7 ± 0.2, 30.0 ± 1.2 and 18.3 ± 1.4 μM respectively. It was found better than the positive control. This was also supported by molecular docking and 3D-QSAR studies for dual antitumor/antibacterial candidate [19] .
Rapolu et al., synthesized a series of 5-(alkyl (1H-indol-3-yl))-2-(substituted)-1,3,4-oxadiazolesusing di (acetoxy) iodobenzene by oxidative cyclisation of N′-benzylidene-(1H-indol-3-yl) alkane hydrazides. These compounds were evaluated for anti-proliferative activity. The compound 6 showed highest activity against division of cancer cell lines [20] .
Puthiyapurayil et al., synthesized a newer combinatorial library of S-substituted-1, 3, 4-oxadiazole bearing N-methyl-4-(trifluoromethyl) phenyl pyrazole moiety (7) and evaluated them as cytotoxic agents [21] .
Zhang et al., reported a newer series of 1, 3, 4-oxadiazole derivatives bearing 1, 4-benzodioxane moiety with antitumor activity. Anti-proliferative activity was evaluated against HEPG2, HELA, SW1116 and BGC823 cell lines. Compound 8 exhibited highest antitumor activity in comparison to 5-fluorouracil which is frequently used in cancer treatment [22] .
Kamal et al., synthesized a newer series of 2-anilinonicotinyl linked 1, 3, 4-oxadiazoles for anticancer evaluation against different cancer cell lines, tubulin polymerization inhibition and effects on cell cycle. Good antiproliferative activity was shown by the compounds where GI50 values ranged between 4.57 and 97.09 μM and the compound9showed to be a potent antitumor agent by inhibiting tubulin polymerization. Western blotting demonstrated the depolymerisation of the microtubules by the compound 9and resulted in cell cycle arrest at G2/M phase causing activation of caspase-3 activity and apoptotic cell death [23] .
Kiselyov et al., synthesized a newer series of 1, 3, 4-oxadiazole as anti-proliferative, anti-mitotic, and microtubule destabilizing compounds after filtering the agents with in vivo phenotypic sea urchin embryo assay. Compounds 10 and 11 were evaluated for cell proliferation, cell cycle arrest at the G2/M phase, cellular microtubule distribution, and at last, in vitro microtubule assembly using purified tubulin with the help of conventional assays on A549 human cancer cell line [24] . Lam koket al., synthesized a newer series of oxadiazole analogues as mushroom tyrosinase inhibitor. The compound 18 showed maximum tyrosinase inhibitory activity (IC50 value of 0.87 ± 0.16 µM). The in-silico protein-ligand docking using AUTODOCK 4.1 studies on compound 18 with significant binding energy value of -5.58 kcal/mol showed that the piperazine moiety in compound 18showedan extensive hydrophobic contact and 2.9 Å H-bonding with residue Glu 182 in the active site [27] . The Fig. 1 showed the structure of oxadiazoles with anticancer activity. Karthikeyan et al., synthesized a newer series of 2, 4-dichloro-5-fluorophenyl containing 1, 3, 4-oxadiazole analogues followed by spectral characterization, elemental analyses havingantibacterial and antifungal activities. The compound 34 exhibited excellent antimicrobial activity [38] .
Antibacterial
1, 3, 4-Oxadiazoles as Therapeutic Heterocycles
Advances in Biomedicine and Pharmacy Vol. 1 (1) (39) and performed DPPH, hydrogen peroxide, and nitric oxide radical scavenging assays to evaluate in vitro antioxidant activity [40] .
Padmavat et al., synthesized a newer class of oxadiazoles as antioxidant agents [41] . The compound 40 was found to be promising among the series. The Fig. 4 showed the structure of oxadiazoles with antioxidant activity. Rapolu et al., synthesized a series of 5-(alkyl(1H-indol-3-yl))-2-(substituted)-1,3,4-oxadiazoles using di (acetoxy) iodobenzene followed by their anti-inflammatory activity using rat paw edema method. Compound 6 exhibited the best anti-inflammatory activity [20] .
Gilani et al., synthesized a series of 1,3,4-oxadiazole analogues of isoniazid and performed their antiinflammatory, ulcerogenic, analgesic, and lipid peroxidation activities by using a standard protocol. Among these, compound 41 showed maximum anti-inflammatory and analgesic activity with 84.00 ± 1.66 (% inhibition ± SEM after 4 h) and 70.37 ± 1.67 (% inhibition ± SEM after 4 h) respectively [7] .
Manjunatha et al., synthesized oxadiazole analogues and evaluated their anti-inflammatory, analgesic, ulcerogenic and antimicrobial activities. Compound, 42 exhibited maximum activity [42] . The Fig. 5 showed the structure of oxadiazoles with anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities. (Fig. 6) . Tan cytotoxic effects with EC50 values of 1.63 (HBsAg) and 2.96 (HBeAg) μM (Fig. 7) [44].
Miscellaneous Activities
Guda et al., synthesized a newer series of sila-substituted 1,3,4-oxadiazoles and evaluated theiranti-allergic activity on IgE/Ag-stimulated RBL-2H3 cells at 50 and 100 μM concentrations. Compounds bearing sulfonyl moiety with bis(trimethylsilyl)-1,3,4-oxadiazoles (45) showed better antiallergic activities (Fig. 8 ) [45] . [6] Gudipati R, Anreddy RNR and Manda S., "Synthesis, characterization and anticancer activity of certain 3-{4-(5-mercapto-1, 3, 4-oxadiazole-2-yl) phenylimino} indolin-2-one derivatives", Saudi Pharm. J., 19: 153-158, 2011 . 
